PharmaSources, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event CPhI & P-MEC China E-Trade Season from August to December 2020. Consisting of the three sessions "Top API Exporters & Products", "Popular Natural Extracts for Health and Pharma" and "P-MEC China Webinar: Russia Pharmaceutical Manufacturing and Machinery", the E-Trade Season is to facilitate digital sourcing solutions, learning opportunities and business connections for global pharmaceutical practitioners.
The Chinese pharmaceutical market is estimated to reach $161.8 billion by 2023 and take a 30% share of the global market. Among all the industry segments, APIs, natural extracts and pharma machinery are the most export-oriented, creating the export value of 33.68 billion, 2.37 billion and 242.29 million respectively in year 2019.
With the outbreak of COVID-19, the Chinese pharma industry is facing more challenges and uncertainties, including production slowdowns and barred exporting supply chains. The cancellation or postponement of the major pharmaceutical events has also lessened the opportunities of face-to-face communication and exchanges within the pharma community.
"COVID-19 has changed the environment for export trade, and we are launching our event against the eventful time." commented Zing Zhou, Senior Director of PharmaSources, "This E-Trade Season, spanning the pharma sectors of APIs, natural extracts and machinery, will cast massive exposure of the local pharma manufacturers instantly towards the global markets, as well as broaden the souring choices for international buyers."











(All Rights Reserved)